Preferred Label : Diclofenac Potassium;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 15307-81-0; L4D5UA6CB4;
Is substance : O;
UNII : L4D5UA6CB4;
InChIKey : KXZOIWWTXOCYKR-UHFFFAOYSA-M;
Origin ID : M0006286;
UMLS CUI : C0282131;
Currated CISMeF NLP mapping
- Exact mapping(s) to DCI
- Related record
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
http://www.has-sante.fr/portail/jcms/c_1727812/fr/voltarendolo
2014
false
false
false
France
evaluation of the transparency committee
guidelines for drug use
treatment outcome
administration, oral
risk factors
cardiovascular diseases
diclofenac
diclofenac
Diclofenac Potassium
Diclofenac Potassium
insurance, health, reimbursement
pain
fever
cyclooxygenase inhibitors
cyclooxygenase inhibitors
---
http://www.has-sante.fr/portail/jcms/c_1728833/fr/voltarene-emulgel-voltarendolo
2014
false
true
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
risk factors
cardiovascular diseases
diclofenac
diclofenac
Diclofenac Potassium
Diclofenac Potassium
insurance, health, reimbursement
pain
fever
cyclooxygenase inhibitors
cyclooxygenase inhibitors
Diclofenac Diethylamine
administration, cutaneous
diclofenac
diclofenac
tendinitis
osteoarthritis
edema
postoperative edema
post-traumatic edema
tendinopathy
---
Diclofenac - Update to Heart and Stroke Related Safety Information and Decrease in
the Maximum Recommended Daily Dose for Tablets and Suppositories - For Health Professionals
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/41701a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/41703a-fra.php
2014
false
false
false
false
Canada
French
English
pharmacovigilance note
administration, oral
administration, rectal
diclofenac
diclofenac
diclofenac
diclofenac, combinations
drug combinations
Diclofenac Potassium
Diclofenac Potassium
Diclofenac Sodium
Diclofenac Sodium
myocardial infarction
cardiovascular diseases
risk factors
guidelines for drug use
stroke
thrombosis
risk
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
Cardiotoxicity
---
